Esophageal and Pancreatic Cancers
An esophageal stent is a stent (tube) placed in the esophagus to keep a blocked area open so the patient can swallow soft food and liquids. Esophageal stents may be self-expandable metallic stents, or made of plastic, or silicone, and may be used in the treatment ofesophageal cancer.Some cancers can obstruct the normal openings within the gastrointestinal tract. Obstructions may cause great discomfort and interfere with digestive function. Our physicians use endoscopes to insert stents into narrowed areas in order to relieve obstructions. Enteral stenting does not cure cancer; we use it to improve symptoms and enhance quality of life.
Endoscopic mucosal resection (EMR)
EMR has been advocated for early esophageal cancers (that is, those that are superficial and confined to the mucosa only) and has been shown to be a less invasive, safe, and effective nonsurgical therapy for early squamous-cell carcinoma. It has also been shown to have be safe and effective for early adenocarcinoma arising in Barrett’s esophagus. The prognosis after treatment with EMR is comparable to surgical resection. Compared to traditional surgery, EMR patients benefit from faster recovery times and a lower risk of complications.
multidisciplinary approach to pancreatic cancer treatment. Patients have access to promising investigational treatments long before they are widely available at other hospitals. U.S. News & World Report has consistently ranked both our cancer and gastroenterology programs among the best in the United States.
Benign pancreatic diseases, including pancreatitis
We offer a full spectrum of diagnostic and treatment options for pancreatitis and other benign pancreatic diseases.
CATE’s esophageal cancer team includes specialists from several fields who work together to perform expert diagnostic and treatment options for patients with any stage of adenocarcinoma or squamous cell carcinoma of the esophagus.